IL88848A - קביעה אימונולוגיתהמשתמשת באסטרים, תיואסטרים ואמידים בתור כמילומינסצנטים - Google Patents

קביעה אימונולוגיתהמשתמשת באסטרים, תיואסטרים ואמידים בתור כמילומינסצנטים

Info

Publication number
IL88848A
IL88848A IL8884888A IL8884888A IL88848A IL 88848 A IL88848 A IL 88848A IL 8884888 A IL8884888 A IL 8884888A IL 8884888 A IL8884888 A IL 8884888A IL 88848 A IL88848 A IL 88848A
Authority
IL
Israel
Prior art keywords
specific binding
assay
conjugate
analyte
group
Prior art date
Application number
IL8884888A
Other languages
English (en)
Other versions
IL88848A0 (en
Original Assignee
London Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26837818&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL88848(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by London Diagnostics Inc filed Critical London Diagnostics Inc
Publication of IL88848A0 publication Critical patent/IL88848A0/xx
Publication of IL88848A publication Critical patent/IL88848A/he

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
IL8884888A 1987-12-31 1988-12-30 קביעה אימונולוגיתהמשתמשת באסטרים, תיואסטרים ואמידים בתור כמילומינסצנטים IL88848A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14004087A 1987-12-31 1987-12-31
US29184388A 1988-12-29 1988-12-29

Publications (2)

Publication Number Publication Date
IL88848A0 IL88848A0 (en) 1989-07-31
IL88848A true IL88848A (he) 1994-02-27

Family

ID=26837818

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8884888A IL88848A (he) 1987-12-31 1988-12-30 קביעה אימונולוגיתהמשתמשת באסטרים, תיואסטרים ואמידים בתור כמילומינסצנטים

Country Status (14)

Country Link
EP (2) EP0322926B2 (he)
JP (1) JP3172522B2 (he)
KR (1) KR900700888A (he)
AT (2) ATE183311T1 (he)
AU (1) AU635890B2 (he)
CA (1) CA1341613C (he)
DE (3) DE3891212T1 (he)
ES (1) ES2134185T5 (he)
GB (4) GB2232995B (he)
GR (1) GR3031647T3 (he)
IE (1) IE61614B1 (he)
IL (1) IL88848A (he)
NZ (1) NZ227506A (he)
WO (1) WO1989006231A1 (he)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918192A (en) * 1986-10-06 1990-04-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
DE3750503T2 (de) * 1986-10-22 1995-02-09 Abbott Lab Chemilumineszierende Acridinium- und Phenantridiniumsalze.
US4950613A (en) * 1988-02-26 1990-08-21 Gen-Probe Incorporated Proteted chemiluminescent labels
WO1989012232A1 (en) * 1988-06-08 1989-12-14 London Diagnostics, Inc. Assays utilizing sensitizer-induced production of detectable signals
US5656426A (en) * 1988-08-01 1997-08-12 Chiron Diagnostics Corporation Functionaized hydrophilic acridinium esters
US5227489A (en) * 1988-08-01 1993-07-13 Ciba Corning Diagnostics Corp. Stable hydrophilic acridinium esters suitable for liposome encapsulation
US5663074A (en) * 1988-09-26 1997-09-02 Chiron Diagnostics Corporation Nucleophilic polysubstituted aryl acridinium ester conjugates and syntheses thereof
CA1339491C (en) * 1988-09-26 1997-10-07 Say-Jong Law Nucleophilic polysubstituted aryl acridinium ester and uses thereof
US5340716A (en) * 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
JPH07509245A (ja) * 1992-07-20 1995-10-12 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 新規化学発光化合物およびその使用方法
US6002000A (en) * 1992-07-20 1999-12-14 Dade Behring Marburg Gmbh Chemiluminescent compounds and methods of use
WO1994003812A1 (en) * 1992-07-31 1994-02-17 Syntex (U.S.A.) Inc. Photoactivatable chemiluminescent matrices
JP3584379B2 (ja) * 1993-02-04 2004-11-04 持田製薬株式会社 アクリジニウム化合物およびアクリジニウム化合物複合体
US5395752A (en) * 1993-03-19 1995-03-07 Ciba Corning Diagnostics Corp. Long emission wavelength chemiluminescent compounds and their use in test assays
US5491072A (en) * 1993-05-17 1996-02-13 Lumigen, Inc. N-alkylacridan carboxyl derivatives useful for chemiluminescent detection
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
US5731148A (en) * 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
EP0761652A1 (en) * 1995-08-01 1997-03-12 Mochida Pharmaceutical Co., Ltd. Acridinium compound having a plurality of luminescent groups and binding groups, and conjugate thereof
DE69711188T2 (de) * 1996-07-16 2002-09-05 Nederlanden Staat Dibenzodihydropyridincarbonsäureester und ihre anwendung in chemolumineszenz-untersuchungsverfahren
US6165800A (en) * 1997-05-30 2000-12-26 Bayer Corporation Chemiluminescent energy transfer conjugates and their uses as labels in binding assays
EP1019379B1 (en) * 1997-08-21 2005-10-19 Maine Medical Center Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein
US6723851B2 (en) * 2001-10-31 2004-04-20 Quest Diagnostics Investment Incorporated Chemiluminescent compounds and use thereof
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1461877A (en) * 1974-02-12 1977-01-19 Wellcome Found Assay method utilizing chemiluminescence
EP0082636B2 (en) * 1981-12-11 2006-10-18 The Welsh National School of Medicine Luminescent labelling materials and procedures
US4687747A (en) * 1984-07-02 1987-08-18 Mallinckrodt, Inc. Phenanthridinium ester as a labelling compound in luminometric immunoassay
JPS6261969A (ja) * 1985-09-06 1987-03-18 アモコ・コーポレーション アクリジニウムエステルの合成法
DE3645292C2 (de) * 1986-08-22 1997-12-11 Hoechst Ag Chemilumineszenzimmunoassays und ein Verfahren zu ihrer Herstellung
US4745181A (en) * 1986-10-06 1988-05-17 Ciba Corning Diagnostics Corp. Polysubstituted aryl acridinium esters
DE3750503T2 (de) * 1986-10-22 1995-02-09 Abbott Lab Chemilumineszierende Acridinium- und Phenantridiniumsalze.
ES2074051T3 (es) * 1987-09-21 1995-09-01 Gen Probe Inc Ensayo de proteccion homogeneo.
NL8703075A (nl) † 1987-12-18 1989-07-17 Nederlanden Staat Acridiniumverbindingen als chemiluminescentie-merkstof.

Also Published As

Publication number Publication date
IE883895L (en) 1989-06-30
ES2134185T5 (es) 2004-11-01
EP0322926B2 (en) 2004-03-31
DE3891212T1 (de) 1991-01-10
EP0916658A1 (en) 1999-05-19
GR3031647T3 (en) 2000-02-29
ATE425970T1 (de) 2009-04-15
EP0322926A3 (en) 1991-03-20
NZ227506A (en) 1992-06-25
KR900700888A (ko) 1990-08-17
GB2251942A (en) 1992-07-22
AU635890B2 (en) 1993-04-08
ATE183311T1 (de) 1999-08-15
GB9203181D0 (en) 1992-04-01
GB2232995B (en) 1992-10-14
DE3856358D1 (de) 1999-09-16
AU2927089A (en) 1989-08-01
EP0916658B1 (en) 2009-03-18
GB2252161A (en) 1992-07-29
IE61614B1 (en) 1994-11-16
DE3856597D1 (de) 2009-04-30
JPH03501772A (ja) 1991-04-18
GB9203179D0 (en) 1992-04-01
DE3856358T3 (de) 2004-12-30
WO1989006231A1 (en) 1989-07-13
CA1341613C (en) 2011-05-10
EP0322926A2 (en) 1989-07-05
JP3172522B2 (ja) 2001-06-04
DE3856358T2 (de) 2000-04-20
GB2252162A (en) 1992-07-29
GB9014479D0 (en) 1990-10-03
EP0322926B1 (en) 1999-08-11
GB9203180D0 (en) 1992-04-01
IL88848A0 (en) 1989-07-31
GB2232995A (en) 1991-01-02
ES2134185T3 (es) 1999-10-01

Similar Documents

Publication Publication Date Title
IL88848A (he) קביעה אימונולוגיתהמשתמשת באסטרים, תיואסטרים ואמידים בתור כמילומינסצנטים
US5284951A (en) Hydrolytically stable chemiluminescent labels and their conjugates, and assays therefrom
EP0618231B1 (de) Immunologisch aktive Konjugate und ein Verfahren zu ihrer Herstellung
FI92698B (fi) Harvinaisten maametallien 2,2-bispyridyylikryptaatteja, menetelmiä niiden valmistamiseksi, niiden synteesin välituotteita ja niiden käyttö fluoresoivina merkkiaineina
US5346996A (en) Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
EP0635019B1 (en) Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
US5532171A (en) Phenothiazine derivatives, their production and use
Mikola et al. Syntheses and properties of luminescent lanthanide chelate labels and labeled haptenic antigens for homogeneous immunoassays
CS273617B2 (en) Method of resorufine's derivatives production
GB2045239A (en) Intermediates useful in the synthesis of chemiluminescent- labeled conjugates for use in specific binding assays
GB2041920A (en) Intermediates useful in the synthesis of chemiluminescent phthalhydrazide-labelled conjugates
US5338847A (en) Hydrolytically stable chemiluminescent labels and their conjugates, and assays therefrom by adduct formation
US4226993A (en) Amino-functionalized phthalhydrazides
US5321136A (en) Peri substituted fused ring chemiluminescent labels and their conjugates, and assays therefrom
EP2457916A1 (en) Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof
Adamczyk et al. Evaluation of chemiluminescent estradiol conjugates by using a surface plasmon resonance detector
US4133949A (en) Dicarboxylic acid esters of cardiac glycosides
EP0846126A1 (en) Tricyclic antidepressant derivatives and conjugated useful in immunoassays
FR2625565A1 (fr) Esters, thioesters et amides chimioluminescents perfectionnes, et analyses les utilisant
IL43554A (en) Process for preparing testosterone-3-(3-carboxymethyl)-oxime-tyrosine methyl ester

Legal Events

Date Code Title Description
RH Patent void
KB Patent renewed
KB Patent renewed